Stay updated on Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page.

Latest updates to the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page
- Check6 days agoChange DetectedNew quick-access actions were added to the history page: 'Check who can join' and 'Find Contact Information', improving navigation to eligibility and contact details. The page now displays Revision: v3.6.0 and removes the previous Revision: v3.5.5 entry.SummaryDifference0.3%

- Check13 days agoChange DetectedA new revision entry, v3.5.5, has been added to the history and the prior v3.5.4 entry has been removed. This reflects an updated release noted in the page's revision history.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision (v3.5.4) was added to the page, replacing the previous revision (v3.5.3) in the history. This updates the revision metadata for the study record history.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page’s footer revision label was updated from **v3.5.2** to **v3.5.3**, indicating a minor ClinicalTrials.gov site/version update rather than a change to the recorded trial information.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the history.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page.